Evidence map›Paper›PMID 26383638›Full record

ArticlePloS one2015

Phosphoenolpyruvate Carboxykinase, a Key Enzyme That Controls Blood Glucose, Is a Target of Retinoic Acid Receptor-Related Orphan Receptor α.

Hiroshi Matsuoka, Akiho Shima, Daisuke Kuramoto, Daisuke Kikumoto, Takashi Matsui, Akihiro Michihara

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Genomic and insulin-mediated control of metabolic homeostasis by the mosquito ecdysone-induced gene E93.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Review
  5. Article
  6. Hyperpolarized [2-ACS sensors · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. A Review ofMolecules (Basel, Switzerland) · 2023
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Lactate-FortifiedNutrients · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hiroshi MatsuokaLaboratory of Genome Function and Pathophysiology, Faculty of Pharmacy and Pharmaceutical Science, Fukuyama University, Fukuyama, Hiroshima, Japan.
Akiho ShimaLaboratory of Genome Function and Pathophysiology, Faculty of Pharmacy and Pharmaceutical Science, Fukuyama University, Fukuyama, Hiroshima, Japan.
Daisuke KuramotoLaboratory of Genome Function and Pathophysiology, Faculty of Pharmacy and Pharmaceutical Science, Fukuyama University, Fukuyama, Hiroshima, Japan.
Daisuke KikumotoLaboratory of Genome Function and Pathophysiology, Faculty of Pharmacy and Pharmaceutical Science, Fukuyama University, Fukuyama, Hiroshima, Japan.
Takashi MatsuiLaboratory of Genome Function and Pathophysiology, Faculty of Pharmacy and Pharmaceutical Science, Fukuyama University, Fukuyama, Hiroshima, Japan.
Akihiro MichiharaLaboratory of Genome Function and Pathophysiology, Faculty of Pharmacy and Pharmaceutical Science, Fukuyama University, Fukuyama, Hiroshima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphoenolpyruvate carboxykinase (PEPCK) catalyzes a committed and rate-limiting step in hepatic gluconeogenesis, and its activity is tightly regulated to maintain blood glucose levels within normal limits. PEPCK activity is primarily regulated through hormonal control of gene transcription. Transcription is additionally regulated via a cAMP response unit, which includes a cAMP response element and four binding sites for CCAAT/enhancer-binding protein (C/EBP). Notably, the cAMP response unit also contains a putative response element for retinoic acid receptor-related orphan receptor α (RORα). In this paper, we characterize the effect of the RORα response element on cAMP-induced transcription. Electrophoresis mobility shift assay indicates that RORα binds this response element in a sequence-specific manner. Furthermore, luciferase reporter assays indicate that RORα interacts with C/EBP at the PEPCK promoter to synergistically enhance transcription. We also found that cAMP-induced transcription depends in part on RORα and its response element. In addition, we show that suppression of RORα by siRNA significantly decreased PEPCK transcription. Finally, we found that a RORα antagonist inhibits hepatic gluconeogenesis in an in vitro glucose production assay. Taken together, the data strongly suggest that PEPCK is a direct RORα target. These results define possible new roles for RORα in hepatic gluconeogenesis.

Indexed as

Blood GlucoseCCAAT-Enhancer-Binding ProteinsCyclic AMPHep G2 CellsHumansNuclear Receptor Subfamily 1, Group F, Member 1Phosphoenolpyruvate Carboxykinase (ATP)Blood GlucoseCCAAT-Enhancer-Binding ProteinsCyclic AMPNuclear Receptor Subfamily 1, Group F, Member 1Phosphoenolpyruvate Carboxykinase (ATP)RORA protein, human

Identifiers

PMID26383638
PMCPMC4575163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.